German Government Adjusts Drug Pricing Policy Following Industry Concerns

Germany is reportedly revising its proposed drug pricing reforms, moving from variable to fixed discounts on medicines. This policy shift comes after significant opposition from pharmaceutical firms. Several major companies had indicated they would reconsider their investment strategies in Germany due to the initial reform proposals.